Security Snapshot

Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS) Institutional Ownership

CUSIP: 75915K309

13F Institutional Holders and Ownership History from Q2 2022 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$8.20

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
RGLS
Shares outstanding
66,505,186
Price per share
$8.20
Price from insider filings
$8.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • RGLS - Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 75915K309.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 0 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

75915K309

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
RGLS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 3.9% $9,086,956 2,696,426 Vivo Opportunity Fund Holdings, L.P. 31 Mar 2025
Point72 Asset Management, L.P. 0.3% -93% $1,977,487 -$30,197,722 241,157 -94% Point72 Asset Management, L.P. 30 Jun 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
15
Latest
n/a
Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$132,628 $8.20 0
2025 Q3 $8.20 0
2025 Q2 0 $0 -$105,304,835 $8.16 0
2025 Q1 53,596,381 $105,311,940 +$3,105,761 $1.75 74
2024 Q4 53,508,570 $84,543,374 -$5,126,517 $1.58 68
2024 Q3 56,729,933 $89,079,771 +$3,280,059 $1.57 69
2024 Q2 54,841,321 $97,892,529 +$13,518,084 $1.78 60
2024 Q1 45,620,114 $128,657,473 +$103,077,800 $2.88 42
2023 Q4 9,168,367 $11,735,268 +$40,056 $1.28 23
2023 Q3 8,956,428 $12,343,312 +$1,002,811 $1.37 22
2023 Q2 8,228,751 $12,096,772 +$2,407,893 $1.47 21
2023 Q1 6,598,665 $5,593,075 -$77,466 $0.85 22
2022 Q4 6,670,905 $9,138,408 -$4,945 $1.37 21
2022 Q3 6,668,921 $11,336,000 +$3,422,009 $1.70 19
2022 Q2 4,622,322 $9,565,000 +$9,565,000 $2.06 22
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .